loadpatents
Patent applications and USPTO patent grants for Chu; Xin-Jie.The latest application filed is for "piperazine derivatives as hiv protease inhibitors".
Patent | Date |
---|---|
Piperazine derivatives as HIV protease inhibitors Grant 10,138,255 - Williams , et al. Nov | 2018-11-27 |
Piperazine derivatives as HIV protease inhibitors Grant 9,840,478 - Williams , et al. December 12, 2 | 2017-12-12 |
Piperazine Derivatives As Hiv Protease Inhibitors App 20170073354 - Williams; Peter D. ;   et al. | 2017-03-16 |
Substituted pyrrolidine-2-carboxamides Grant 9,371,280 - Bartkovitz , et al. June 21, 2 | 2016-06-21 |
Piperazine Derivatives As Hiv Protease Inhibitors App 20160159752 - Williams; Peter D. ;   et al. | 2016-06-09 |
Substituted pyrrolidine-2-carboxamides Grant 8,993,614 - Bartkovitz , et al. March 31, 2 | 2015-03-31 |
Novel Imidazolines as dual inhibitors of MDM2 and MDMX App 20140148443 - Chu; Xin-Jie ;   et al. | 2014-05-29 |
Substituted Pyrrolidine-2-carboxamides App 20130324531 - Bartkovitz; David Joseph ;   et al. | 2013-12-05 |
Substituted Pyrrolidine-2-carboxamides App 20130244958 - Bartkovitz; David Joseph ;   et al. | 2013-09-19 |
Chiral cis-imidazolines Grant 8,513,239 - Bartkovitz , et al. August 20, 2 | 2013-08-20 |
Substituted Heteroaryl 2',3',7',7a'-tetrahydrospiro[pyrrole-3,6'-pyrrolo[1,2-c]imidazole]-1',2(1- H,5'h)-dione App 20130053410 - Bartkovitz; David Joseph ;   et al. | 2013-02-28 |
Substituted pyrrolidine-2-carboxamides Grant 8,354,444 - Bartkovitz , et al. January 15, 2 | 2013-01-15 |
Spiroindolinone pyrrolidines Grant 8,217,044 - Chu , et al. July 10, 2 | 2012-07-10 |
Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones App 20120071499 - Chu; Xin-Jie ;   et al. | 2012-03-22 |
Substituted Hexahydropyrrolo[1,2-c]imidazolones App 20120065210 - Chu; Xin-Jie ;   et al. | 2012-03-15 |
Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists App 20120046306 - Bartkovitz; David Joseph ;   et al. | 2012-02-23 |
N-substituted Pyrrolidines App 20120010235 - Chu; Xin-Jie ;   et al. | 2012-01-12 |
Spiroindolinone pyrrolidines Grant 8,088,815 - Bartkovitz , et al. January 3, 2 | 2012-01-03 |
Spiroindolinone Pyrrolidines App 20110269809 - Chu; Xin-Jie ;   et al. | 2011-11-03 |
Thiazolyl-benzimidazoles Grant 8,044,213 - Cai , et al. October 25, 2 | 2011-10-25 |
N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions Grant 8,017,607 - Bartkovitz , et al. September 13, 2 | 2011-09-13 |
Halo-substituted pyrimidodiazepines Grant 8,003,785 - Cai , et al. August 23, 2 | 2011-08-23 |
Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives Grant 7,994,321 - Bartkovitz , et al. August 9, 2 | 2011-08-09 |
Pyrazolo[3,4-d]pyrimidine derivatives Grant 7,968,554 - Bartkovitz , et al. June 28, 2 | 2011-06-28 |
Spiroindolinone Pyrrolidines App 20110130398 - Bartkovitz; David Joseph ;   et al. | 2011-06-02 |
Novel N-substituted-pyrrolidines As Inhibitors Of Mdm2-p-53 Interactions App 20110086854 - Bartkovitz; David Joseph ;   et al. | 2011-04-14 |
Thiazolyl-Benzimidazoles App 20100160308 - Cai; Jianping ;   et al. | 2010-06-24 |
Substituted Pyrrolidine-2-Carboxamides App 20100152190 - Bartkovitz; David Joseph ;   et al. | 2010-06-17 |
Halo-substituted Pyrimidodiazepines App 20090318408 - Cai; Jianping ;   et al. | 2009-12-24 |
4-aminopyrimidine-5-one derivatives Grant 7,615,634 - Bartkovitz , et al. November 10, 2 | 2009-11-10 |
Chiral Cis-imidazolines App 20090111789 - Bartkovitz; David Joseph ;   et al. | 2009-04-30 |
PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES App 20090048274 - Bartkovitz; David Joseph ;   et al. | 2009-02-19 |
Substituted hydantoins Grant 7,427,635 - Chu , et al. September 23, 2 | 2008-09-23 |
2,6-diaminopyridine derivatives Grant 7,423,051 - Bartkovitz , et al. September 9, 2 | 2008-09-09 |
4-Aminothiazole derivatives Grant 7,423,053 - Chen , et al. September 9, 2 | 2008-09-09 |
Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity App 20080177036 - Chen; Li ;   et al. | 2008-07-24 |
Substituted Thieno[3,2-C]Pyridine-7-Carboxylic Acid Derivatives App 20080045562 - Bartkovitz; David Joseph ;   et al. | 2008-02-21 |
4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives App 20070060607 - Bartkovitz; David Joseph ;   et al. | 2007-03-15 |
4-Aminopyrimidine-5-one derivatives Grant 7,157,455 - Bartkovitz , et al. January 2, 2 | 2007-01-02 |
4-aminopyrimidine-5-one derivatives App 20060229330 - Bartkovitz; David Joseph ;   et al. | 2006-10-12 |
Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity Grant 7,045,591 - Chen , et al. May 16, 2 | 2006-05-16 |
Substituted hydantoins App 20060041146 - Chu; Xin-Jie ;   et al. | 2006-02-23 |
4-Aminothiazole derivatives App 20060014958 - Chen; Li ;   et al. | 2006-01-19 |
2,6-Diaminopyridine derivatives App 20060014708 - Bartkovitz; David Joseph ;   et al. | 2006-01-19 |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity App 20050239711 - Chen, Li ;   et al. | 2005-10-27 |
Diaminothiazoles Grant 6,818,663 - Chu , et al. November 16, 2 | 2004-11-16 |
4-aminopyrimidine-5-one derivatives App 20040162303 - Bartkovitz, David Joseph ;   et al. | 2004-08-19 |
Diaminothiazoles App 20040006058 - Chu, Xin-Jie ;   et al. | 2004-01-08 |
Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activity App 20030229200 - Chen, Li ;   et al. | 2003-12-11 |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity Grant 6,600,015 - Chen , et al. July 29, 2 | 2003-07-29 |
Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity App 20020143141 - Chen, Li ;   et al. | 2002-10-03 |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity App 20010056179 - Chen, Li ;   et al. | 2001-12-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.